These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 457492)

  • 41. [Results of treatment for laryngeal carcinoma in Würzburg].
    Bohndorf W; Höcker G
    Strahlentherapie; 1976 Feb; 151(2):132-43. PubMed ID: 1258083
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The effect of primary tumor localization on radiotherapy for supraglottic and glottic cancer].
    Goleń M; Trybalska G; Namysłowski G
    Otolaryngol Pol; 1998; 52(1):45-51. PubMed ID: 9591421
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [LATEST OBSERVATIONS ON HISTOLOGICAL MODIFICATIONS OF THE HUMAN LARYNX AFTER COBALT TELETHERAPY].
    MATTIOLI V; FINI-STORCHI O; LIPPI L
    Boll Mal Orecch Gola Naso; 1964; 82():15-27. PubMed ID: 14164240
    [No Abstract]   [Full Text] [Related]  

  • 44. [The results of cobalt therapy for carcinoma of the larynx (author's transl)].
    Ghilezan N
    J Radiol Electrol Med Nucl; 1977 May; 58(5):353-8. PubMed ID: 886530
    [TBL] [Abstract][Full Text] [Related]  

  • 45. T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy.
    Chera BS; Amdur RJ; Morris CG; Kirwan JM; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):461-6. PubMed ID: 20153124
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Conventional fractionation should not be the standard of care for T2 glottic cancer.
    Dixon LM; Douglas CM; Shaukat SI; Garcez K; Lee LW; Sykes AJ; Thomson D; Slevin NJ
    Radiat Oncol; 2017 Nov; 12(1):178. PubMed ID: 29137654
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease.
    Frata P; Cellai E; Magrini SM; Bonetti B; Vitali E; Tonoli S; Buglione M; Paiar F; Barca R; Fondelli S; Polli C; Livi L; Biti G
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1387-94. PubMed ID: 16115737
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stages 1 and 2 epidermoid carcinoma of the glottic larynx: involvement of the anterior commissure.
    Stevenson JM; Juillard GJ; Selch MT
    Radiology; 1992 Mar; 182(3):797-9. PubMed ID: 1535897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Curative radiotherapy for anterior commissure laryngeal carcinoma.
    Persky MS; Lagmay VM; Cooper J; Constantinides M; O'Leary R
    Ann Otol Rhinol Laryngol; 2000 Feb; 109(2):156-9. PubMed ID: 10685566
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intensity-modulated radiotherapy for early glottic cancer: transition to a new standard of care?
    Samuels MA; Freedman LM; Elsayyad N
    Future Oncol; 2016 Nov; 12(22):2615-2630. PubMed ID: 27502431
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radiation therapy for larynx carcinoma: long-term results of stage I glottic carcinoma.
    Chatani M; Matayoshi Y; Masaki N
    Strahlenther Onkol; 1993 Feb; 169(2):102-6. PubMed ID: 8451724
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Build-up and build-down measurements with thin LiF-teflon dosimeters with special reference to radiotherapy of carcinoma of the larynx.
    Koskinen MO; Spring E
    Strahlentherapie; 1973 May; 145(5):565-70. PubMed ID: 4761817
    [No Abstract]   [Full Text] [Related]  

  • 53. Risk factors for voice quality after radiotherapy for early glottic cancer.
    Hocevar-Boltezar I; Zargi M; Strojan P
    Radiother Oncol; 2009 Dec; 93(3):524-9. PubMed ID: 19846231
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Second primary respiratory tract malignancies in glottic carcinoma.
    Wagenfeld DJ; Harwood AR; Bryce DP; van Nostrand AW; DeBoer G
    Cancer; 1980 Oct; 46(8):1883-6. PubMed ID: 7427891
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Local control and site of failure in radically irradiated supraglottic laryngeal cancer.
    Ghossein NA; Bataini JP; Ennuyer A; Stacey P; Krishnaswamy V
    Radiology; 1974 Jul; 112(1):187-92. PubMed ID: 4832491
    [No Abstract]   [Full Text] [Related]  

  • 56. Larynx motion considerations in partial larynx volumetric modulated arc therapy for early glottic cancer.
    Bahig H; Nguyen-Tan PF; Filion É; Roberge D; Thanomsack P; de Guise J; Blais D; Doucet R; Létourneau-Guillon L; Lambert L
    J Med Imaging Radiat Oncol; 2017 Oct; 61(5):666-673. PubMed ID: 28557310
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Post-irradiation reactions in patients with laryngeal cancer after continuous and intermittent Co-60 teletherapy].
    Peszyński J; Borowska B; Kozuch-Gdak W; Horoch A; Kupisz K
    Otolaryngol Pol; 1986; 40(6):409-13. PubMed ID: 3601396
    [No Abstract]   [Full Text] [Related]  

  • 58. Megavoltage radiation therapy for supraglottic carcinoma. Results of treatment.
    Wang CC
    Radiology; 1973 Oct; 109(1):183-6. PubMed ID: 4205836
    [No Abstract]   [Full Text] [Related]  

  • 59. Treatment outcomes of the patients with early glottic cancer treated with initial radiotherapy and salvaged by conservative surgery.
    Harada A; Sasaki R; Miyawaki D; Yoshida K; Nishimura H; Ejima Y; Kitajima K; Saito M; Otsuki N; Nibu K
    Jpn J Clin Oncol; 2015 Mar; 45(3):248-55. PubMed ID: 25502310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Supervoltage radiotherapy for carcinoma of the larynx the Johns Hopkins Hospital results 1961 to 1967.
    Lott S; el-Mahdi AM; Hazra T
    Johns Hopkins Med J; 1972 Apr; 130(4):244-53. PubMed ID: 4621905
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.